Current Edition

Psychedelics Make a Comeback to Treat Mental Health Conditions

The FDA has approved only two products to treat TRD, and several companies are evaluating products with psychedelic properties as a new approach to previously untreatable mental health conditions. Jaime Polychrones at Clarivate shows how psychedelics are being explored worldwide, with Johns Hopkins opening the Center for Psychedelic and Conscious Research in the US and in the UK, the Imperial College opened the Centre for Psychedelic Research.